OTTMUSG00000016293 Inhibitors
The proposed inhibitors primarily function by altering the proteolytic environment within the cell, which can indirectly affect the functionality of SPINT5. For instance, inhibitors like E-64, Pepstatin A, Leupeptin, MG132, Aprotinin, Lactacystin, AEBSF, ALLN, Chymostatin target various proteases or proteasomal activities, leading to an accumulation of proteins or altering the balance between proteases and their inhibitors. This altered balance can impact SPINT5 by changing its interaction dynamics with other proteins, affecting its stability, or influencing its regulatory roles within these modified proteolytic environments. Furthermore, compounds such as Marimastat and Ilomastat, known for inhibiting matrix metalloproteases, can modify the extracellular matrix remodeling processes. These changes in the extracellular environment might indirectly impact SPINT5's functionality by affecting the cellular context and signaling pathways in which SPINT5 operates. Similarly, Bestatin, as an aminopeptidase inhibitor, can influence peptide processing and degradation, potentially affecting SPINT5's interactions or stability within the cell.
In summary, the inhibition of SPINT5 through these chemicals involves indirect mechanisms that primarily focus on altering the proteolytic balance and environmental context within the cell. These changes can influence SPINT5's functional interactions, stability, and regulatory roles, thereby leading to its inhibition. Each proposed inhibitor works through a unique pathway, showcasing the complex interplay of cellular processes that can be targeted to indirectly modulate the activity of proteins like SPINT5.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a potent inhibitor of cysteine proteases. Inhibition of these proteases can lead to an accumulation of proteins that require degradation, potentially leading to an altered cellular environment that inhibits SPINT5 function by affecting its interaction with other proteins or its processing. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is a broad-spectrum inhibitor of serine and cysteine proteases. Its inhibition of these proteases can change the protease-inhibitor dynamics in the cell, potentially inhibiting SPINT5 by affecting its interactions or stability within the altered cellular proteolytic environment. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. Inhibition of the proteasome can lead to the accumulation of ubiquitinated proteins, potentially disrupting normal protein turnover and indirectly inhibiting SPINT5 by altering its interactions or stability. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a serine protease inhibitor. Its inhibition of serine proteases can influence the protease-inhibitor balance in the cell, potentially leading to the inhibition of SPINT5 by affecting its interaction with target proteases or its regulatory role. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin is a specific inhibitor of the proteasome. By inhibiting proteasomal degradation, it can indirectly affect SPINT5 function by altering the cellular environment, particularly the dynamics of protein turnover and degradation. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF is a serine protease inhibitor. Its action on serine proteases can indirectly inhibit SPINT5 by affecting the balance of proteases and their inhibitors in the cell, potentially influencing SPINT5's activity or stability. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is a broad-spectrum matrix metalloprotease inhibitor. While its primary targets are metalloproteases, its alteration of the extracellular matrix remodeling can indirectly affect SPINT5 function by changing the cellular context in which SPINT5 operates. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
GM 6001 (Ilomastat), another matrix metalloprotease inhibitor, can alter the extracellular environment. This alteration can indirectly inhibit SPINT5 by affecting cellular signaling and interactions in which SPINT5 may be involved. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Bestatin is an aminopeptidase inhibitor. By inhibiting aminopeptidases, it can indirectly influence SPINT5 activity by altering peptide processing and degradation, potentially affecting SPINT5's functional interactions or stability. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
Chymostatin is a chymotrypsin-like serine protease inhibitor. Its inhibition of these proteases can indirectly inhibit SPINT5 by altering the proteolytic balance in the cell, which can affect SPINT5's interactions with other proteins or its own processing and stability. | ||||||